NGS Endometrial Carcinoma

Whole sequencing: POLE, TP53 and pathogenic changes in 150 genes of the TruSight Oncology 500 Assay (Illumina). To order this analysis, please contact the Customer Service Center: contact@viollier.ch or +41 848 121 121. This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG shall arrange for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tarmed)